Vancouver, Canada (June 20, 2023) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, finalized another customer deal to advance precision medicine initiatives. This latest partnership, with New Jersey-based CareWell Health, will help them improve health outcomes...
Vancouver, Canada (May 30th, 2023) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, announces record year-over-year quarterly sales growth for Q1 2023, as well as a record implementation time for getting its enterprise molecular lab and...
North Carolina - GenXys and Dendi have announced a partnership to provide comprehensive test results and clinical decision support to clinicians nationwide. The collaboration will deliver a tightly-integrated solution that utilizes a technology-driven workflow to interpret pharmacogenomic (PGx) results and recommend the most optimal treatment...
GenXys, being a global software as a service (SaaS) company, provides solutions to healthcare providers and labs who are looking for reliable pharmacogenetics (PGx) implementations with smart clinical decision support. One of our core values is quality, which means providing software you can trust and...
Offering safety, security and peace of mind for advanced healthcare teams and their molecular labs GenXys provides the world’s most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare’s biggest challenges: inappropriate (“trial-and-error”) prescribing. Adverse drug reactions are a top five cause of...
Vancouver, Canada - GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, recently secured a customer deal with Indiana-based TrueScripts, a thriving pharmacist-founded Prescription Benefit Management (PBM) company. Together, this high-quality partnership will advance precision medicine initiatives and continue to accelerate the...
GenXys recognized for achievements in precision prescribing platform NEW YORK, December 7, 2022 -- CB Insights today named GenXys to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022. "From reimagining clinical care, to leveraging tech like AR/VR to improve...
Vancouver, Canada (November 2, 2022) – GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in...
Vancouver, Canada (July 28, 2022) – GenXys, the award-winning global leader in precision prescribing software with embedded pharmacogenetic (PGx) capability, recently solidified deals with three North American laboratory companies – Inagene, SRx Health and Immunogenomics of Texas. Two of these labs use the cutting-edge Agena...
Vancouver, Canada (May 19, 2022) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, recently finalized another customer deal to advance precision medicine initiatives with Ohio-based Flexsus, the laboratory division of FlexHealth. Combined with GenXys’ best-in-class precision prescribing...
